成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 394-69-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 394-69-4
Chemical Structure| 394-69-4
Structure of 394-69-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 394-69-4 ]

Related Doc. of [ 394-69-4 ]

Alternatived Products of [ 394-69-4 ]
Product Citations

Product Citations

Boyao Zhang ; George-Eugen Maftei ; Bartosz Bartmanski , et al. DOI:

Abstract: Organic carcinogens, in particular DNA-reactive compounds, contribute to the irreversible initiation step of tumorigenesis through introduction of genomic instability. Although carcinogen bioactivation and detoxification by human enzymes has been extensively studied, carcinogen biotransformation by human-associated bacteria, the microbiota, has not yet been systematically investigated. We tested the biotransformation of 68 mutagenic carcinogens by 34 bacterial species representative for the upper and lower human gastrointestinal tract and found that the majority (41) of the tested carcinogens undergo bacterial biotransformation. To assess the functional consequences of microbial carcinogen metabolism, we developed a pipeline to couple gut bacterial carcinogen biotransformation assays with Ames mutagenicity testing and liver biotransformation experiments. This revealed a bidirectional crosstalk between gut microbiota and host carcinogen metabolism, which we validated in gnotobiotic mouse models. Overall, the systematic assessment of gut microbiota carcinogen biotransformation and its interplay with host metabolism highlights the gut microbiome as an important modulator of exposome-induced tumorigenesis.

Purchased from AmBeed: ; ; ; ; ; ; 117-39-5 ; ; ; ; 62-44-2 ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Product Details of [ 394-69-4 ]

CAS No. :394-69-4 MDL No. :MFCD01685511
Formula : C9H6FN Boiling Point : No data available
Linear Structure Formula :- InChI Key :WMFXCDGQRHJFKL-UHFFFAOYSA-N
M.W : 147.15 Pubchem ID :115243
Synonyms :

Calculated chemistry of [ 394-69-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 41.7
TPSA : 12.89 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.82 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.86
Log Po/w (XLOGP3) : 1.94
Log Po/w (WLOGP) : 2.79
Log Po/w (MLOGP) : 2.27
Log Po/w (SILICOS-IT) : 2.91
Consensus Log Po/w : 2.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.65
Solubility : 0.332 mg/ml ; 0.00225 mol/l
Class : Soluble
Log S (Ali) : -1.84
Solubility : 2.15 mg/ml ; 0.0146 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.96
Solubility : 0.0162 mg/ml ; 0.00011 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.57

Safety of [ 394-69-4 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H320-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 394-69-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 394-69-4 ]

[ 394-69-4 ] Synthesis Path-Downstream   1~16

  • 2
  • quinoline-5-diazonium-tetrafluoroborate [ No CAS ]
  • [ 394-69-4 ]
  • 3
  • [ 611-34-7 ]
  • [ 394-69-4 ]
YieldReaction ConditionsOperation in experiment
55% With tetrafluoroboric acid; sodium nitrite; at 0℃; for 1h; Preparation LIII 5-fluoro-1,2,3,4-tetrahydroquinoline [0363] 5-fluoroquinoline [0364] To a suspension of 5-aminoquinoline (50 g, 347 mmol) in 48percent HBF4 (200 mL) at 0° C. was added portionwise sodium nitrite. This was stirred for 1 hour and then poured into 1:1 ethyl acetate/diethyl ether (500 mL). The resulting suspension was filtered and the solid dried. This solid (82.5 g, 338 mmol) was added portionwise to refluxing xylene (1 L) and stirred for 2 hours then allowed to cool. The xylene was decanted off and the residue dissolved in 1N hydrochloric acid (600 mL). After neutralization with sodium carbonate, the mixture was extracted with ethyl acetate (10.x.500 mL). The extracts were dried over sodium sulfate, filtered and the volatiles removed under reduced pressure. The residue was subjected to silica gel chromatography, eluting with 10-20percent diethyl ether in hexanes. Fractions containing product were combined and concentrated under reduced pressure to provide 28.1 g (55percent) of the desired compound. MS (EI, m/z) C9H6FN (M+1) 148.0 [0365] Reduction [0366] A mixture of 5-fluoroquinoline (28.1 g), 5percent palladium on carbon (5.6 g) in methanol was shaken over night at 40° C. under 60 psi hydrogen. The mixture was filtered through celite and concentrated under reduced pressure. The residue was subjected to silica gel chromatography, eluting with 5-10percent ethyl acetate in hexanes. Fractions containing product were combined and concentrated under reduced pressure to provide 22.5 g (78percent) of the title compound. [0367] MS (EI, m/z) C9H10FN (M+1) 152.0
24.5% With tetrafluoroboric acid; sodium nitrite; In xylene; at 0℃;Reflux; To a suspension of 5-aminoquinoline (lO.Og, 0.069 mol) in 48percent HBF4 (40 mL) at 0°C was added portionwise sodium nitrite. This was stirred for 1 hour and then poured into 1 : 1 ethyl acetate/diethyl ether (50 mL). The resulting suspension was filtered and the solid dried. This solid was added portionwise to refluxing xylene (80 mL) and stirred for 2 hours then allowed to cool. The xylene was decanted off and the residue was dissolved in IN aqueous hydrochloric acid (100 mL). After neutralization with sodium carbonate, the mixture was extracted with ethyl acetate (3 x 80 mL). The extracts were dried over sodium sulfate, filtered and the volatiles were removed in vacuo. The residue was purified by silica gel column chromatography, eluting with 2percent ethyl acetate in petroleum ether to afford 5-fluoroquinoline as a colorless oil (2.5 g, 24.5percent).'H-NMR (300 MHz, CDC13) delta 8.93 - 8.98 (m, 1H), 8.43 - 8.46 (m, H), 7.92 (d, / = 8.4 Hz, 1H), 7.62 - 7.78 (m, 1H), 7.41 - 7.49 (m, 1H), 7.22 - 7.26 (m, 1H)
800 mg With tetrafluoroboric acid; sodium nitrite; at 0℃; for 1h; To a solution of quinolin-5 -amine (2 g, 13.9 mmol) in 10 mL of 48percent HBF4 at 0°C was added sodium nitrite (933 mg, 13.5 mmol) portionwise. This was stirred for 1 hour and then poured into 1 : 1 ethyl acetate diethyl ether mixture (50 mL). The resulting suspension was filtered and the solid was dried. This solid was added portionwise to refluxing xylene (30 mL) and stirred for 3 hours, then allowed to cool. The xylene was decanted off and the residue was dissolved in IN HC1 (50 mL). After neutralization with NaHC03, the mixture was extracted with ethyl acetate (3 x 50 mL). The extracts were dried over sodium sulfate, filtered and the volatiles were removed under reduced pressure. The residue was purified by silica gel chromatography (3percent EtOAc/PE) to afford 800 mg of title compound as colorless oil. LC-MS: m/z 148.2 (M+H)+
800 mg With tetrafluoroboric acid; sodium nitrite; at 0℃; for 1h; To a solution of quinolin-5-amine (2 g, 13.9 mmol) in 10 mL of 48percent HBF4 at 0° C. was added sodium nitrite (933 mg, 13.5 mmol) portionwise. This was stirred for 1 hour and then poured into 1:1 ethyl acetate diethyl ether mixture (50 mL). The resulting suspension was filtered and the solid was dried. This solid was added portionwise to refluxing xylene (30 mL) and stirred for 3 hours, then allowed to cool. The xylene was decanted off and the residue was dissolved in 1N HCl (50 mL). After neutralization with NaHCO3, the mixture was extracted with ethyl acetate (3×50 mL). The extracts were dried over sodium sulfate, filtered and the volatiles were removed under reduced pressure. The residue was purified by silica gel chromatography (3percent EtOAc/PE) to afford 800 mg of title compound as colorless oil. LC-MS: m/z 148.2 (M+H)+
800 mg With tetrafluoroboric acid; sodium nitrite; at 0℃; for 1h; To a solution of quinolin-5 -amine (2 g, 13.9 mmol) in 10 mL of 48percent HBF4 at 0°C was added sodium nitrite (933 mg, 13.5 mmol) portionwise. This was stirred for 1 hour and then poured into 1 : 1 ethyl acetate diethyl ether mixture (50 mL). The resulting suspension was filtered and the solid was dried. This solid was added portionwise to refluxing xylene (30 mL) and stirred for 3 hours, then allowed to cool. The xylene was decanted off and the residue was dissolved in IN HC1 (50 mL). After neutralization with NaHC03, the mixture was extracted with ethyl acetate (3 x 50 mL). The extracts were dried over sodium sulfate, filtered and the volatiles were removed under reduced pressure. The residue was purified by silica gel chromatography (3percent EtOAc/PE) to afford 800 mg of title compound as colorless oil. LC-MS: m/z 148.2 (M+H)+

  • 4
  • [ 394-69-4 ]
  • [ 152167-85-6 ]
  • 5
  • [ 91-22-5 ]
  • [ 396-30-5 ]
  • [ 394-68-3 ]
  • [ 394-69-4 ]
  • [ 16650-32-1 ]
  • 7
  • [ 394-69-4 ]
  • 5-fluoro-6-nitroquinoline [ No CAS ]
  • 8
  • [ 91-22-5 ]
  • [ 394-68-3 ]
  • [ 394-69-4 ]
  • [ 16650-32-1 ]
  • 5,6-difluoro-5,6-dihydroquinoline [ No CAS ]
  • 9
  • [ 372-19-0 ]
  • [ 56-81-5 ]
  • [ 396-32-7 ]
  • [ 394-69-4 ]
  • 10
  • [ 394-69-4 ]
  • [ 455955-27-8 ]
  • 11
  • [ 394-69-4 ]
  • [ 455955-29-0 ]
  • 12
  • [ 394-69-4 ]
  • 4-(5-fluoro-quinolin-2-yl)-piperazine-1-carbaldehyde [ No CAS ]
  • 13
  • [ 394-69-4 ]
  • [ 455955-34-7 ]
  • 14
  • [ 394-69-4 ]
  • 1-[4-(6-nitro-5-fluoroquinolin-2-yl)piperazin-1-yl]ethanone [ No CAS ]
  • 15
  • [ 394-69-4 ]
  • 5-fluoro-1,10-phenanthroline [ No CAS ]
  • 16
  • [ 394-69-4 ]
  • [ 161038-18-2 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 394-69-4 ]

Fluorinated Building Blocks

Chemical Structure| 396-30-5

[ 396-30-5 ]

6-Fluoroquinoline

Similarity: 0.89

Chemical Structure| 1128-61-6

[ 1128-61-6 ]

6-Fluoro-2-methylquinoline

Similarity: 0.85

Chemical Structure| 325-14-4

[ 325-14-4 ]

7-(Trifluoromethyl)quinoline

Similarity: 0.80

Chemical Structure| 1229037-03-9

[ 1229037-03-9 ]

4-Chloro-5-fluoroquinoline

Similarity: 0.79

Chemical Structure| 394-68-3

[ 394-68-3 ]

8-Fluoroquinoline

Similarity: 0.74

Related Parent Nucleus of
[ 394-69-4 ]

Quinolines

Chemical Structure| 396-30-5

[ 396-30-5 ]

6-Fluoroquinoline

Similarity: 0.89

Chemical Structure| 1128-61-6

[ 1128-61-6 ]

6-Fluoro-2-methylquinoline

Similarity: 0.85

Chemical Structure| 325-14-4

[ 325-14-4 ]

7-(Trifluoromethyl)quinoline

Similarity: 0.80

Chemical Structure| 1229037-03-9

[ 1229037-03-9 ]

4-Chloro-5-fluoroquinoline

Similarity: 0.79

Chemical Structure| 394-68-3

[ 394-68-3 ]

8-Fluoroquinoline

Similarity: 0.74

; ;